MICOT PHARMA-B (02335.HK): H shares included in eligible list under Stock Connect

NewTimeSpace News: On 7 September 2026, Shaanxi Micot Pharmaceutical Technology Co., Ltd. (stock code: 02335) voluntarily announced that, pursuant to announcements issued by the Shanghai Stock Exchange and the Shenzhen Stock Exchange on 4 September 2026 and 7 September 2026 respectively, the company's H shares had been included in the eligible share list under the Stock Connect schemes (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect), effective from 7 September 2026.

Following the inclusion, eligible mainland Chinese investors will be able to buy and sell the company's shares through the Shanghai Stock Exchange and the Shenzhen Stock Exchange. The company expects the inclusion to further broaden its shareholder base, increase the trading liquidity of its shares and support its innovation-driven and sustainable growth in the long run.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.